WSA 2009 - BIT Life Sciences' 2nd Annual World Summit of Antivirals 2009 (WSA2009)

The information of WSA-2009
(High appreciate that you can announcement the summit news on your web site first)

BIT Life Sciences' 2nd Annual World Summit of Antivirals 2009
Theme: Meeting the Health Challenges in the Globalization
Time: July 18-20, 2009
Place: Beijing, China
Website: http://www.bitlifesciences.com/wsa2009

BIT Life Sciences' World Summit Antivirals (WSA) is a focused event for updating the current advances in worldwide R & D of Novel Antiviral Therapeutics. The anticipated attendees will represent top-level decision makers from leading biotech, pharmaceutical and healthcare organizations. WSA is preparing to meet the demands on expert views; up-to-the-minute industry intelligences; professional presentations and poster sessions. WSA also provides an ideal forum for the promotion of relevant companies, products, technologies and services.

Highlights of BIT Life Sciences' 2nd Annual World Summit of Antivirals 2009:
Invite 20-30 high profile speakers from distinguished companies leading the antivirals trend
Offer 150-200 parallel presentations and discussions update current novel R & D status
Arrange 80 scientific and technological posters to share the new findings and breakthroughs
Invite 30-50 exhibitors to demonstrate their product and technology development
Provide 5-10 Showcases for most promising and fast growing companies in antiviral R & D
Schedule 1 to 1 network meeting for your business and collaboration demands.

The topics include:
Track 1: Basic Sciences, Clinical Applications and Public Health
Track 1- 1: Viruses and Genomics
Track 1- 2: Viral Drug Resistance and Genotyping
Track 1- 3: Retroviruses
Track 1- 4: Respiratory, Herpes Virus, Dengue Fever and Other Emerging Viruses
Track 1- 5: Antivirals and Intervention and Behavioral Intervention

Track 2: Novel Antivirals Drug Discovery
Track 2- 1: Upstream Platform Technologies for Antiviral Drug Discovery
Track 2- 2: Medicinal Chemistry and and Rational Drug Design of Antivirals
Track 2- 3: Novel Drug Delivery System for Antivirals
Track 2- 4: Antisense as Antivirals
Track 2- 5: DNA and RNA polymerase Inhibitors
Track 2- 6: Fusion Inhibitors
Track 2- 7: Interferons
Track 2- 8: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Track 2- 9: Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs/NtRTIs)
Track 2- 10: Protease and Integrase Inhibitors
Track 2- 11: Neuraminidase Inhibitors (NIs)

Track 3: Antivirals Biotherapeutics
Track 3- 1: New Biomarkers for Antiviral Drug Discovery
Track 3- 2: Antibodies for Antiviral Therapeutics
Track 3- 3: Novel Antiviral Vaccines
Track 3- 4: Antiviral Immunomodulators/Immunostimulants, Interferons and other Biopharmaceuticals

Track 4: Pipeline Update and Business Development
Track 4- 1: Antivirals on HIV
Track 4- 2: Antivirals on HCV and HBV
Track 4- 3: Antivirals on Herpes Viruses and HPV
Track 4- 4: Influenza/Avian Flu and Respiratory Antivirals

Training Course
Course 1: Cross Infection Control and Combination Therapy
Course 2: Molecular Diagnositcs for Virus Infection

To keep the moment going, we are calling for speakers, papers, sponsorships, co-organizers and exhibitors from international institutions and organizations.

For more information, please see: http://www.bitlifesciences.com/wsa2009

Contact info:

Chris Huang
Program Coordinator
Organizing Committee of WSA-2008, China
26 Gaoneng Street, Room 405,
Dalian High-tech Zone,
Dalian, LN 116025, China
Email: chris-AT-bit-wsa.com
Tel: 0086-411-84799609*813
Fax: 0086-411-84799629